Canada DNA Biochemical Inc. was founded by a team of antibiotic engineers with decades of experience in the production of pharmaceutical medicines, including erythromycin, penicillin, interferons, and staphlokinase, etc.

We have employed our expertise in pharmaceutical manufacturing in the harvesting of the medicinal properties of fungal mushrooms through techniques like hybridization, deep layer fermentation and many others, and the resulting products have been phenomenal.

Our Cordyceps sinensis (CS-4 strain) currently has the highest content of adenosine (0.3%) on the market, and our Coriolus versicolor (Corio PSP) is also among the elite in terms of polysaccharides content (22%). All of our products are manufactured according to GMP standards, and their contents verified by independent laboratories.

To be the best medicinal mushroom manufacturer and supplier is our goal, and we strive very hard towards that goal every single day.